Canine extracutaneous mast-cell tumours consisting of connective tissue mast cells. 2000

N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
Laboratory of Comparative Pathology, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.

Two cases of canine extracutaneous mast-cell tumours were encountered, originating from the mucosa of either the oral cavity or the small intestine. The dogs had no neoplasms in the skin. Immunohistochemical and ultrastructural studies demonstrated that the neoplastic cells had the features of connective tissue mast cells. It would seem, therefore, that at least some extracutaneous forms of the neoplasm originate from connective tissue mast cells. Heparin was a useful cytological marker to diagnose this type of mast-cell tumour.

UI MeSH Term Description Entries
D007078 Ileal Neoplasms Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL). Cancer of ILEUM,Cancer of the ILEUM,Cancer, Ileal,Ileal Cancer,Cancers, Ileal,ILEUM Cancer,ILEUM Cancers,Ileal Cancers,Ileal Neoplasm,Neoplasm, Ileal,Neoplasms, Ileal
D008297 Male Males
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012515 Mast-Cell Sarcoma A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow. Mastocytoma, Malignant,Sarcoma, Mast-Cell,Malignant Mastocytoma,Malignant Mastocytomas,Mast Cell Sarcoma,Mast-Cell Sarcomas,Mastocytomas, Malignant,Sarcoma, Mast Cell,Sarcomas, Mast-Cell
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
December 2004, The veterinary quarterly,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
November 2012, Veterinary pathology,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
March 2016, Veterinary and comparative oncology,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
April 1958, Arthritis and rheumatism,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
August 1964, Biulleten' eksperimental'noi biologii i meditsiny,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
September 2016, Veterinary and comparative oncology,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
January 2005, Journal of comparative pathology,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
November 2017, Journal of comparative pathology,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
December 2021, Scientific reports,
N Iwata, and K Ochiai, and T Kadosawa, and M Takiguchi, and T Umemura
March 2015, Acta veterinaria Hungarica,
Copied contents to your clipboard!